Letters to the Editor
- 1 July 1998
- journal article
- letter
- Published by Wiley in Movement Disorders
- Vol. 13 (4) , 749-753
- https://doi.org/10.1002/mds.870130425
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1Movement Disorders, 1997
- Botulinum A toxins: units versus unitsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997
- Reconstituted Botulinum Toxin Type A Does Not Lose Potency in Humans If It Is Refrozen or Refrigerated for 2 Weeks Before UseNeurology, 1997
- Dose standardisation of botulinum toxin.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Dose standardisation of botulinum toxinThe Lancet, 1994
- Dose standardisation of botulinum toxinThe Lancet, 1990
- DOSE STANDARDISATION OF BOTULINUM TOXINThe Lancet, 1989
- Diurnal responsiveness to apomorphineNeurology, 1987
- Fluctuations of disability in Parkinson's disease – clinical aspectsPublished by Elsevier ,1981
- Influence of nerve‐ending activity and of drugs on the rate of paralysis of rat diaphragm preparation by Cl. botulinum type A toxinThe Journal of Physiology, 1962